Cancer Drugs
The latest news about Cancer Drugs: headlines, AI summaries and the full story from every source.
- Vir Biotechnology Licenses Technology to Gilead for Up to $1.9 Billion
- Royalty Pharma Stock as a Diversified Alternative to Revolution Medicines
- AstraZeneca Q2 Earnings Beat on Strong Cancer Drug Sales
- AstraZeneca Reports Strong Q2 Earnings Driven by Cancer Drug Sales
- EU Drug Regulator Panel Recommends Eight New Medicines Including Merck's Keytruda and AbbVie’s Maviret
- Pfizer Outlines Post-2028 Growth Strategy Focused on Obesity Drugs
- Erasca Reports Negative Phase 1 Trial Data, Shares Drop 37%